Clinical Evidence

Delve into clinical research studies and more 

Clinical research lies at the heart of who we are. Vantive uses scientific evidence systematically and transparently, to inform the development of state-of-the-art solutions for patients around the world. Here you can find various studies, white papers and articles concerning important topics across the wide range of therapy areas served by Vantive.

254 results

HDx therapy enabled by Theranova
Determining factors for hemodiafiltration to equal or exceed the performance of expanded hemodialysis.
Visit resource site
HDx therapy enabled by Theranova
Differences in drug removal between standard high-flux and medium cut-off dialyzers in a case of severe vancomycin toxicity.
Visit resource site
PD
Discrepancy between prescribed and actual APD prescription delivery: Identification using cycler remote management technology - Firanek CA, et al.
Visit resource site
HDx therapy enabled by Theranova
Disruptive technologies for hemodialysis: medium and high cutoff membranes. Is the future now?
Visit resource site
HDx therapy enabled by Theranova
Distribution of peripheral blood t cell subtypes in hemodialysis patients treated with medium cut-off membranes and high-flux membranes
Visit resource site
HDx therapy enabled by Theranova
Effect of a medium cut-off dialyzer on protein-bound uremic toxins and mineral metabolism markers in patients on hemodialysis.
Visit resource site
HDx therapy enabled by Theranova
Effect of expanded hemodialysis on body composition and nutritional status
Visit resource site
HDx therapy enabled by Theranova
Effect of Expanded Hemodialysis with Theranova® in Patients with COVID-19
Visit resource site
HDx therapy enabled by Theranova
Effect of medium cut-off and high-flux hemodialysis membranes on blood pressure assessed by ambulatory blood pressure monitoring.
Visit resource site
HDx therapy enabled by Theranova
Effectiveness of medium cut-off vs high flux dialyzers: a propensity score matching cohort study
Visit resource site
HDx therapy enabled by Theranova
Effects of a medium cut-off (Theranova®) dialyser on haemodialysis patients: a prospective, cross-over study
Visit resource site
HDx therapy enabled by Theranova
Effects of Different Dialysis Strategies on Inflammatory Cytokine Profile in Maintenance Hemodialysis Patients with COVID-19: A Randomized Trial.
Visit resource site

Vantive is a trademark of Vantive Health LLC or its affiliates.